These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 13678545)
1. Viral patterns of unboosted 908 identified. AIDS Patient Care STDS; 2003 Aug; 17(8):431. PubMed ID: 13678545 [No Abstract] [Full Text] [Related]
2. From amprenavir to GW433908. Gatell JM J HIV Ther; 2001 Nov; 6(4):95-9. PubMed ID: 11740410 [No Abstract] [Full Text] [Related]
3. Evolution of resistance during first-line treatment with boosted fosamprenavir is associated with baseline mutations. Schürmann D; Elston R; Xu F; Kleinkauf N; Wünsche T; Suttorp N AIDS; 2006 Jan; 20(1):138-40. PubMed ID: 16327339 [No Abstract] [Full Text] [Related]
4. The benefits of HIV resistance testing in optimizing drug discovery. Heilek-Snyder G; Bean P Am Clin Lab; 2002 Oct; 21(8):13-4. PubMed ID: 12440169 [No Abstract] [Full Text] [Related]
5. Slow accumulation of HIV resistance mutations: implications for resource-limited settings? Stevens WS J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045 [No Abstract] [Full Text] [Related]
6. Lexiva: blood levels not lowered when taken simultaneously with Nexium. James JS AIDS Treat News; 2005 May; (412):5. PubMed ID: 16047410 [TBL] [Abstract][Full Text] [Related]
7. [Resistance investigations during HIV-therapy is necessary]. Schattenfroh S Dtsch Med Wochenschr; 1998 Feb; 123(7):A7. PubMed ID: 9505940 [No Abstract] [Full Text] [Related]
8. HIV drug resistance testing: an update for the clinician. Rice HL; Zolopa AR AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921 [No Abstract] [Full Text] [Related]
9. [Two year use of Telzir: what are the perspectives?]. Med Mal Infect; 2007 Mar; 37(3):181-6. PubMed ID: 17552082 [No Abstract] [Full Text] [Related]
10. HIV drug resistance in Africa: an emerging problem that deserves urgent attention. Moreno M; Caballero E; Mateus RM; Samba F; Gil E; Falcó V AIDS; 2017 Jul; 31(11):1637-1639. PubMed ID: 28481772 [No Abstract] [Full Text] [Related]
11. [Incorporation of the test of resistance to antiretroviral drugs in clinical practice]. Soriano V; Briones C Med Clin (Barc); 1999 Mar; 112(11):412-5. PubMed ID: 10231774 [No Abstract] [Full Text] [Related]
12. Amprenavir in pre-treated patients: virological and immunological response in a cohort of 45 patients. Bogner JR; Eberle J; Troendle U; Goebel FD Eur J Med Res; 2003 Feb; 8(2):49-55. PubMed ID: 12626281 [TBL] [Abstract][Full Text] [Related]
13. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians. Mascolini M; Wensing AM; Boucher CA IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306 [No Abstract] [Full Text] [Related]
14. New insights into HIV resistance testing: nursing guidelines and implications. Kirton CA; Kurtyka D; Sterken DJ J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302 [TBL] [Abstract][Full Text] [Related]
15. HIV drug resistance testing: data be damned. Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172 [No Abstract] [Full Text] [Related]